Nalaganje...

Mitochondrial hyperactivity as a potential therapeutic target in Parkinson’s disease

Mitochondrial dysfunction is thought to contribute to neurodegeneration in Parkinson’s disease (PD), yet the cellular events that lead to mitochondrial disruption remain unclear. Post-mortem studies of PD patient brains and the use of complex I inhibitors to model the disease previously suggested a...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Transl Med Aging
Main Authors: Mor, Danielle E., Murphy, Coleen T.
Format: Artigo
Jezik:Inglês
Izdano: 2020
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7653964/
https://ncbi.nlm.nih.gov/pubmed/33178902
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tma.2020.07.007
Oznake: Označite
Brez oznak, prvi označite!